Vincent-Philippe Lavallée

16PUBLICATIONS
90CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsNeonatologyPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 19, 2026
Modeling KRAS mutations in KMT2A::MLLT3 acute myeloid leukemia promotes leukemic progression and transcriptional rewiring.

|Jul 22, 2026
In vitro inhibition of STAT5 signaling limits CD8⁺ T cell exhaustion and improves outcomes in adoptive T-cell therapy.

|May 15, 2026
TP53-mutant AML with ribosomal gene loss exhibits impaired protein translation and sensitivity to HSP90 inhibition.

|May 11, 2026
Cell-Free DNA Uncovered Tumor Heterogeneity and Informed Targeted Therapy in a Pediatric Rhabdomyosarcoma.

|Apr 09, 2025
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.

Fadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen

|Mar 19, 2024
Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment.

Damien Maggiorani, Oanh Le, Véronique Lisi

Pageof 3

Frequent Collaborators

5 joint publications

Sébastien Lemieux

4 joint publications

Guy Sauvageau

3 joint publications

Thai Hoa Tran

3 joint publications

Raoul Santiago